CMS's June 2026 interim final rule requires states to implement Medicaid community engagement requirements for certain non-pregnant adults ages 19 to 64 enrolled through the ACA Medicaid expansion group by January 1, 2027. The medical-frailty exemption sits with the enrollee and the state. But when a patient brings the letter to clinic and asks you to sign it, you will need to understand what the rule actually requires -- because what you document will shape whether the exemption holds.
Consider a 34-year-old patient you have managed for three years. She has a seizure disorder, well-controlled on two medications. She works part-time as a cashier, about 12 hours a week, but her schedule is inconsistent and she depends on Medicaid. Under CMS's June 2026 interim final rule on community engagement requirements, she may be in the population subject to the requirement, depending on her coverage category, state implementation rules, and whether she qualifies for an exclusion. You are not the decision-maker -- the state is. But you are, in many cases, the documentation source.
CMS-2454-IFC requires states to implement community engagement requirements for certain non-pregnant adults ages 19 to 64 enrolled through the ACA Medicaid expansion group. States must generally implement by January 1, 2027 -- but the rule permits early adoption. Arkansas DHS began soft implementation July 1, 2026, with no penalties in 2026. Beginning January 1, 2027, ARHOME beneficiaries subject to the requirement must generally complete 80 hours per month; those found noncompliant have 30 days to demonstrate compliance before benefits are suspended.
The rule excludes multiple categories of people from the community-engagement condition, including pregnant and postpartum individuals; certain parents and caretaker relatives of children under 14; some caregivers of dependent individuals with disabilities; people enrolled in Medicare; American Indian and Alaska Native beneficiaries; former foster youth through age 26; certain people transitioning from incarceration; qualifying students; hospice enrollees; people receiving substance-use-disorder treatment; and veterans meeting the applicable disability standard. How a state identifies or verifies each exclusion may differ by available data and state process.
The 80-hour monthly threshold is the core requirement. Qualifying activities include employment, job training, education, caregiving beyond the caretaker exclusion, and volunteering.
The medical-frailty exemption is not a list of conditions you check. Under CMS-2454-IFC, it is a two-part test. The first part asks whether the enrollee falls within one of the five medical-frailty categories: being blind or disabled under the applicable Social Security standard; having a physical, intellectual, or developmental disability; having a substance-use disorder; having a disabling mental disorder; or having a serious or complex medical condition. The second part asks whether the condition significantly impairs the individual's ability to satisfy the 80-hour community-engagement requirement. Both parts have to be satisfied.
That second prong is the one providers often miss when they read the exemption list. A patient with a seizure disorder may fall within the serious-or-complex-medical-condition category, but the diagnosis alone does not establish medical frailty. The state must still determine whether the condition significantly impairs the person's ability to meet the 80-hour requirement. That determination requires looking at seizure frequency, the nature and predictability of breakthrough episodes, any physician restrictions on unsupervised or high-stakes work activities, and the degree to which those medical realities constrain what she can actually do in a month.
CMS has since provided states a three-tier model for operationalizing medical-frailty verification. In Tier 1, available data may establish both a qualifying condition and functional impairment. In Tier 2, diagnosis codes suggest possible frailty but must be paired with additional utilization, pharmacy, DME, or clinical information. Tier 3 covers cases that cannot be resolved from available data and may require individualized review and documentation. CMS describes this as a model rather than a uniform federal mandate; states remain responsible for their own methodologies and code sets.
That Tier 3 pathway is where physicians and clinical staff become part of the verification chain -- not because the rule requires providers to certify anything directly, but because when a state's systems cannot resolve frailty status from claims and eligibility data alone, the enrollee will often present to their provider for a letter or documentation they can submit to the state. What you document in that context carries real weight.
One question your front desk may encounter: can patients simply attest to their medical-frailty status without documentation? The answer is: it depends on the state, and it may change year by year.
In 2027, states may accept a signed statement under penalty of perjury when electronic verification is unavailable. They are not required to do so, and several states are already moving toward documentation or additional-verification requirements. Arkansas, Idaho, Indiana, New Hampshire, North Carolina, and Ohio have signaled requirements for documentation or additional verification rather than relying on self-attestation alone [verify: confirm current implementation posture for each state against published state plan amendments or waiver submissions]. Beginning in 2028, CMS generally limits use of that statement to once per continuous enrollment period, with medical-frailty status reverified at least every 12 months.
Practically: if you serve Medicaid expansion patients and your state is in a documentation-required posture, those patients may arrive asking for clinical letters before they understand what the letter needs to say. Building a clinical workflow for how your practice responds to those requests -- what the clinician documents, who reviews it, and how quickly it can be turned around -- is worth doing before your state's January 2027 go-live, not after.
Community engagement requirements have been legally volatile. Federal courts blocked prior iterations under Trump-era section 1115 waiver authority. The June 2026 interim final rule uses different statutory grounding, but the legal question is not closed. On August 4, 2026, a group of 35 Senate Democrats led by Senators Wyden and Warnock sent a letter to CMS and the Secretary of Health and Human Services expressing serious concerns about coverage losses, administrative burden, and the adequacy of the medical-frailty exemption, and calling on the agency to withdraw or substantially revise the rule before states implement it. That letter does not change the rule's operative status, but it signals that the political environment around implementation remains active.
The legal landscape also changed in September, when a lawsuit was filed challenging CMS's medical-frailty framework on behalf of five Medicaid enrollees and several provider and advocacy groups, arguing CMS unlawfully narrowed the medical-frailty exclusion and created administrative barriers. The litigation does not automatically suspend the rule, but it adds uncertainty to a policy that states are already implementing.
The most important thing to track is not a federal date. It is what your specific states have published about their implementation plans, verification systems, and documentation requirements. Two states with January 2027 go-live dates can have very different operational landscapes: one with a functioning state data-match that routes most enrolled Medicaid patients through Tier 1 or Tier 2 frailty determination without provider involvement, and one that relies heavily on Tier 3 manual review and will push verification burden onto clinicians. That operational difference is what will determine how much time your clinical staff spends on this in the first quarter of 2027.
Care teams should also identify whether their Medicaid managed-care plans, state agencies, or delegated eligibility vendors are the actual requesting entity when documentation requests arrive -- and build an escalation path for time-sensitive coverage-risk notices. The question is not whether your clinicians should invent a generic frailty letter. It is whether your organization knows who will receive the request, which state or managed-care process generated it, what evidence that process accepts, and how quickly the patient can get help before a coverage suspension takes effect.
Discover how Addie helps health systems, post-acute providers, and payers improve throughput, reduce avoidable days, and deliver better transitions of care.
Get Started
